Councils face industry legal threats for campaigns warning against wood burning stoves 

As the UK government considers health warnings for new stoves, investigation reveals industry pressure on councils to shut down clean air campaigns As the UK government considers adding health warnings to new wood burning stoves, as part of a public consultation on solid fuel burning, councils in England are being threatened with ...

2026-03-03T17:15:21+00:005 March 2026|Press release, The BMJ, Uncategorised|

GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death

Findings suggest a potential role in both prevention and treatment of various substance use disorders, say researchers Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis, cocaine, nicotine, and ...

2026-03-03T17:04:54+00:005 March 2026|Press release, The BMJ|

Stimulating international research dialogue on SGLT2 inhibitors and immune risk

The BMJ research: sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases In October 2025, The BMJ published the first nationwide population based cohort study to examine the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and risk of autoimmune rheumatic diseases (ARDs). Drawing on data from more than ...

2026-03-03T15:55:24+00:0027 February 2026|Group news, Our impact, Success stories, The BMJ|

Many post-authorisation studies fail to comply with public disclosure rules 

Better adherence is required for greater research transparency, say researchers  Many post-authorisation studies registered with the European Medicines Agency (EMA) fail to comply with legal requirements and recommendations to make their findings public, finds a study published by The BMJ today. Post-authorisation studies (PAS) are carried out after a medicine is approved ...

2026-02-25T17:43:55+00:0026 February 2026|Press release, The BMJ|

HPV vaccination provides “sustained protection” against cervical cancer 

No indication of waning protection up to 18 years after vaccination, findings show Human papillomavirus (HPV) vaccination is associated with a significantly reduced risk of invasive cervical cancer, with no indication of waning protection up to 18 years after vaccination, finds a study from Sweden published by The BMJ today. HPV is one of the most ...

2026-02-25T17:39:42+00:0026 February 2026|Press release, The BMJ|

The BMJ teams up with top paediatric journals to enhance trial conduct and reporting 

The BMJ has teamed up with leading paediatric journals, JAMA Pediatrics and The Lancet Child & Adolescent Health, to co-publish two papers that will enhance trial conduct and reporting to improve the health of young patients and their families. The papers provide essential checklist items for researchers to include in clinical trial protocols and reports ...

Mental health of children affected by armed conflict: experts call for global commitment and funding

New BMJ Collection calls for evidence based and sustainable mental health support in conflict settings A new collection on Child Mental Health in Conflict Settings published by The BMJ, in partnership with the World Innovation Summit for Health (WISH), calls for evidence based, scalable, sustainable, and long term interventions ...

Menopausal hormone therapy not linked to increased risk of death

Findings in line with guidelines recommending hormone therapy for women who have recently begun menopause with moderate to severe symptoms and no contraindications Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published ...

2026-02-18T16:54:39+00:0019 February 2026|Press release, The BMJ|

Testing menstrual blood for HPV could be “robust alternative” to cervical screening

Could offer a practical way to expand access to screening, say researchers Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician, finds a study from China published by The BMJ today. The researchers say using menstrual blood for HPV ...

2026-02-05T10:00:30+00:005 February 2026|Press release, The BMJ|
Go to Top